Cutler Group LP Corbus Pharmaceuticals Holdings, Inc. Put Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 Apr 26, 2021	SELL	$1.27 - $3.42 $5,207 - $14,022	-4,100 Reduced 97.62%	100 $0
Q3 2020 Oct 27, 2020	BUY	$1.5 - $9.38 $6,300 - $39,396	4,200 New	4,200 $17,000
Q1 2019 May 10, 2019	SELL	$5.76 - $8.95 $38,016 - $59,069	-6,600 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$5.26 - $7.97 $31,560 - $47,820	-6,000 Reduced 47.62%	6,600 $1,000
Q3 2018 Nov 07, 2018	BUY	$4.65 - $7.95 $58,590 - $100,170	12,600 New	12,600 $4,000
Q2 2018 Aug 10, 2018	SELL	$5.05 - $6.8 $5,555 - $7,480	-1,100 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$6.6 - $7.78 $341,220 - $402,226	-51,700 Reduced 97.92%	1,100 $1,000
Q3 2017 Oct 17, 2017	BUY	$5.75 - $7.75 $303,600 - $409,200	52,800	52,800 $3,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.62B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.